Does anyone here subscribe to bioshares?
It woudl be great if someone asked them what they thought of this? It is the first I have heard of another competitor in this area.
Interesting to know if it is open to all applications? and how costly it is?
The results being btter than Lovenox are similar to ACL anyway so no great drama although ACl's generic shoudl be cheaper and covers all applications at this point in time.
interesting, but the time factors in gettign this to market are frustrating
competitors, page-2
Add TSN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.409M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| TSN (ASX) Chart |
Day chart unavailable